William Go, M.D., Ph.D. departed as Chief Medical Officer of Janux Therapeutics, Inc. on June 23, 2026, in a termination without "Cause" under the terms of a severance benefit plan. The Company is searching for a successor and interim responsibilities will be assumed by the existing clinical leadership team. Janux Therapeutics, Inc. is a biotechnology company focused on developing cell therapies.
